Advertisement

Nature's Sunshine Products, Inc. NATR

Set alert

Price alert · NATR

All alert types
12.02 USD -0.23 -1.88%

At close · Nov 2

12.12 +0.10 +0.83%

After hours · Nov 2, 5:29 PM ET

Bid
11.99 × 2
Ask
12.03 × 2
11.93 Day range 12.55
11.93 52-week range 28.14
YTD
-44.30%
1 year
-10.83%
Open
12.27
Prev close
12.25
Mkt cap
211.50M
Vol
140.69K
Avg vol
160.25K
EPS
1.01
P/E
11.90
Div yield
0.00%
More statistics
Low
11.93
High
12.55
Forward P/E
19.18
Beta
0.86
Short ratio
1.79
Inst. own
67.70%
Dividend
0.00
Ex-div date
Mar 25, 2021
50-d avg
14.83
200-d avg
15.66
1y target
22.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 7, 2024Earnings: 0.27; estimate 0; surprise —%
Signals (74)
NameDateAgo
RSI: OversoldOct 21, 20261 week ago
MACD: Buy SignalAug 28, 20262 months ago
RSI: OversoldAug 7, 20262 months ago
MACD: Sell SignalAug 5, 20262 months ago
SMA: BearishAug 4, 20263 months ago
SMA: BullishAug 3, 20263 months ago
MACD: Buy SignalAug 3, 20263 months ago
MACD: Sell SignalJul 17, 20263 months ago
SMA: BearishJul 2, 20264 months ago
SMA: BullishJun 30, 20264 months ago
RSI: OversoldJun 15, 20264 months ago
MACD: Buy SignalJun 10, 20264 months ago
SMA: BearishMay 29, 20265 months ago
RSI: OversoldMay 11, 20265 months ago
SMA: BearishMay 7, 20265 months ago
MACD: Sell SignalMay 1, 20266 months ago
SMA: BullishApr 8, 20266 months ago
MACD: Buy SignalApr 1, 20267 months ago
RSI: OversoldMar 18, 20267 months ago
SMA: BearishMar 13, 20267 months ago
SMA: BullishMar 12, 20267 months ago
SMA: BearishMar 11, 20267 months ago
RSI: OverboughtFeb 25, 20268 months ago
MACD: Sell SignalFeb 18, 20268 months ago
MACD: Buy SignalFeb 13, 20268 months ago
MACD: Sell SignalFeb 10, 20268 months ago
RSI: OverboughtFeb 4, 20269 months ago
RSI: OverboughtJan 30, 20269 months ago
RSI: OverboughtJan 22, 20269 months ago
MACD: Buy SignalJan 16, 20269 months ago
MACD: Sell SignalDec 16, 202510 months ago
MACD: Buy SignalDec 15, 202510 months ago
RSI: OverboughtDec 12, 202510 months ago
RSI: OverboughtDec 5, 202511 months ago
MACD: Sell SignalDec 2, 202511 months ago
RSI: OverboughtNov 21, 202511 months ago
SMA: BullishNov 7, 202512 months ago
SMA: BullishNov 7, 202512 months ago
RSI: OverboughtNov 7, 202512 months ago
MACD: Buy SignalNov 4, 202512 months ago
RSI: OversoldOct 27, 20251 year ago
SMA: BearishOct 16, 20251 year ago
SMA: BearishSep 26, 20251 year ago
MACD: Sell SignalSep 10, 20251 year ago
MACD: Buy SignalSep 3, 20251 year ago
MACD: Sell SignalSep 2, 20251 year ago
MACD: Buy SignalAug 29, 20251 year ago
MACD: Sell SignalAug 28, 20251 year ago
MACD: Buy SignalAug 4, 20251 year ago
SMA: BullishAug 1, 20251 year ago
SMA: BearishJul 25, 20251 year ago
SMA: BullishJul 18, 20251 year ago
SMA: BearishJul 17, 20251 year ago
MACD: Sell SignalJul 15, 20251 year ago
MACD: Buy SignalJul 3, 20251 year ago
MACD: Sell SignalJun 2, 20251 year ago
RSI: OverboughtMay 30, 20251 year ago
RSI: OverboughtMay 15, 20251 year ago
RSI: OverboughtMay 8, 20251 year ago
SMA: BullishMay 7, 20251 year ago
MACD: Buy SignalApr 14, 20251 year ago
RSI: OversoldApr 7, 20251 year ago
MACD: Sell SignalApr 2, 20251 year ago
MACD: Buy SignalApr 1, 20251 year ago
SMA: BearishMar 12, 20251 year ago
MACD: Sell SignalMar 12, 20251 year ago
SMA: BullishMar 6, 20251 year ago
MACD: Buy SignalFeb 27, 20251 year ago
MACD: Sell SignalFeb 20, 20251 year ago
MACD: Buy SignalFeb 5, 20251 year ago
MACD: Sell SignalFeb 3, 20251 year ago
MACD: Buy SignalJan 21, 20251 year ago
RSI: OverboughtDec 2, 20241 year ago
RSI: OverboughtNov 25, 20241 year ago

Key statistics

Market cap
279.91M
Enterprise value
219.79M
Trailing P/E
17.22
Forward P/E
19.18
PEG ratio
0.00
Price / sales
0.63
Price / book
1.79
EPS (TTM)
0.88
Beta
0.86
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
3.82%
Revenue (TTM)
445.10M
Revenue growth
3.10%
Free cash flow
18.59M
Total cash
78.70M
Total debt
15.27M
Return on equity
11.42%
Shares outstanding
18.48M
Short % of float
0.71%
50-day average
14.83
200-day average
15.66

Analyst view

Consensus: none

Price target (mean) 22.00 +83.0% upside
Target (low)
21.00
Target (mean)
22.00
Target (high)
23.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.20.

Earnings history

Financials — quick view

All financials
NATR Revenue — quarterly 116.98M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
NATR Net income — quarterly 3.54M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
NATR EPS — quarterly 0.20
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

NATR recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 20240.000.27——
Aug 8, 2024Jun 1, 20240.000.07——
May 7, 2024Mar 1, 20240.000.12——
Mar 12, 2024Dec 1, 20230.000.45——
Nov 7, 2023Sep 1, 20230.000.15——
Aug 9, 2023Jun 1, 20230.000.12——

Upgrades / downgrades

NATR analyst upgrades and downgrades
DateFirmActionFromTo
Sep 13, 2024Canaccord Genuityinit—Buy
Aug 12, 2024DA DavidsonmainBuyBuy
Mar 13, 2024DA DavidsonmainBuyBuy
Nov 9, 2023DA DavidsonmainBuyBuy
Aug 11, 2023DA DavidsonmainBuyBuy
May 10, 2023DA Davidsonreit—Buy

About Nature's Sunshine Products, Inc.

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.

Sector
Consumer Defensive
Industry
Packaged Foods
Country
United States

News

Your note

Sign in to keep a note on NATR — it syncs with the Stock Master app.

Insider holders

NATR insider holders
InsiderRelationLatest transactionDateShares held
FASCHING STEVEN JDirectorStock Award(Grant)Nov 10, 20242,869
FULLER KEVIN GREGORYOfficerStock Award(Grant)Sep 25, 202411,070
KOPF CURTISDirectorStock Award(Grant)May 5, 202421,927
MOSS RICHARD DDirectorStock Award(Grant)May 5, 202438,629
NORMAN DANIEL C.OfficerStock GiftNov 26, 202459,176
ROERING TESSDirectorStock Award(Grant)May 5, 202421,927

Institution ownership

NATR institution ownership
Holder% heldSharesValueReported
Fosun International Ltd15.87%2,931,96944.42MSep 29, 2024
Wynnefield Capital Management LLC13.39%2,473,68637.48MSep 29, 2024
Prescott Group Capital Management, L.L.C.9.65%1,783,09727.01MSep 29, 2024
Paradigm Capital Management4.61%851,60012.90MSep 29, 2024
Dimensional Fund Advisors LP4.47%826,23712.52MSep 29, 2024
Blackrock Inc.4.42%816,57512.37MSep 29, 2024

Fund ownership

NATR fund ownership
Holder% heldSharesValueReported
Wasatch Microcap Fund3.18%586,6388.89MSep 29, 2024
Vanguard Total Stock Market Index Fund2.15%396,5186.01MSep 29, 2024
iShares Russell 2000 ETF1.71%316,0524.79MOct 30, 2024
Avantis U.S. Small Cap Value ETF1.38%254,9493.86MSep 29, 2024
Vanguard Extended Market Index Fund0.98%180,5892.74MSep 29, 2024
DFA U.S. Micro Cap Series0.88%163,3432.47MJul 30, 2024
Advertisement